Messoud Ashina

Messoud Ashina, Director of the Human Migraine Research Unit in Copenhagen, and Andrea Cipriani, Professor of Psychiatry at the University of Oxford, dive into the complexities of treating migraine. They discuss licensed drug interventions for acute migraine management, highlighting challenges in current treatments and the need for patient input. They tackle the efficacy of both traditional and new medications, emphasizing the importance of tailoring treatments to individual needs, and the critical role of neurologists in improving patient outcomes.

Dr. Tesha Monteith, a dedicated migraine researcher, joins Dr. Messoud Ashina, an expert in migraine treatment, to delve into a groundbreaking phase two study on a monoclonal antibody targeting PACAP for migraine prevention. They highlight its efficacy and safety compared to placebo, address the pressing need for new treatments, and share insights on reported adverse effects. The discussion also hints at exciting future research directions that could transform migraine management. This is vital listening for anyone interested in migraine solutions!

Dr. Tesha Monteith, a PACAP biology expert, and Dr. Messoud Ashina, a migraine therapy specialist, delve into the revolutionary role of PACAP in migraine prevention. They discuss a groundbreaking study on a monoclonal antibody targeting PACAP, revealing its crucial functions in migraine triggers. The two also explore PACAP's vasodilatory effects and how intravenous PACAP infusion impacts specific arteries. Tune in for insights on potential new therapeutic approaches that could change migraine management forever!